CCI Approves TPG Scion’s Acquisition of Schott Poonawalla Stake

06 Mar 2025 CW Team

TPG Scion SG Pte. Ltd. is a newly established special-purpose investment vehicle incorporated in Singapore on 11th October 2024, specifically for this transaction. Currently, it has no operational presence in India. It is affiliated with the TPG Group, a global, diversified investment firm founded in 1992. The TPG Group, which operates across multiple asset classes including private equity, real estate, and infrastructure, manages investments worldwide. The transaction is ultimately controlled by an entity advised by affiliates of TPG Inc., the ultimate holding company of the group.

Schott Poonawalla Private Limited (SPPL), the target company, is engaged in the development, manufacturing, and sale of pharmaceutical packaging solutions. Its product portfolio includes sterile and non-sterile glass containers such as ampoules, vials, cartridges, and prefilled syringes, which are critical components for the pharmaceutical and biotechnology industries. The company specialises in converting tubular glass into primary packaging solutions, ensuring high standards of safety and integrity for pharmaceutical formulations.

Strategic Importance of the Acquisition The acquisition aligns with TPG’s strategy of investing in high-growth sectors, particularly healthcare and life sciences. With India being a global leader in pharmaceutical manufacturing, the demand for high-quality primary packaging solutions has surged, driven by the rise in vaccine production, biologics, and injectable therapies.

The CCI’s approval paves the way for enhanced investments, technological advancements, and global expertise infusion in India's pharmaceutical packaging segment. The partnership between TPG and SPPL is expected to strengthen supply chain efficiencies, improve manufacturing capabilities, and support innovation in sterile and injectable packaging solutions.

Market and Industry Outlook India’s pharmaceutical packaging market is witnessing robust growth, propelled by increasing regulatory requirements, demand for biologics, and the rise of single-dose drug delivery systems. The expansion of vaccine production and the growth of biosimilars and novel therapies have amplified the need for advanced packaging solutions.

With global investors such as TPG entering the segment, the industry is poised for enhanced technological collaborations, automation in manufacturing, and sustainable packaging innovations. The acquisition of a stake in Schott Poonawalla Private Limited is expected to strengthen India’s position as a global hub for pharmaceutical packaging, ensuring compliance with stringent international standards while catering to the evolving needs of the pharmaceutical industry.

Your next big infra connection is waiting at RAHSTA 2025 – Asia’s Biggest Roads & Highways Expo, Jio World Convention Centre, Mumbai. Don’t miss out!

The Competition Commission of India (CCI) has approved the proposed acquisition of a stake in Schott Poonawalla Private Limited (SPPL) by TPG Scion SG Pte. Ltd., marking a significant development in the pharmaceutical packaging sector. The acquisition will be executed through a secondary share purchase from Serum Institute of India Private Limited. TPG Scion SG Pte. Ltd. is a newly established special-purpose investment vehicle incorporated in Singapore on 11th October 2024, specifically for this transaction. Currently, it has no operational presence in India. It is affiliated with the TPG Group, a global, diversified investment firm founded in 1992. The TPG Group, which operates across multiple asset classes including private equity, real estate, and infrastructure, manages investments worldwide. The transaction is ultimately controlled by an entity advised by affiliates of TPG Inc., the ultimate holding company of the group. Schott Poonawalla Private Limited (SPPL), the target company, is engaged in the development, manufacturing, and sale of pharmaceutical packaging solutions. Its product portfolio includes sterile and non-sterile glass containers such as ampoules, vials, cartridges, and prefilled syringes, which are critical components for the pharmaceutical and biotechnology industries. The company specialises in converting tubular glass into primary packaging solutions, ensuring high standards of safety and integrity for pharmaceutical formulations. Strategic Importance of the Acquisition The acquisition aligns with TPG’s strategy of investing in high-growth sectors, particularly healthcare and life sciences. With India being a global leader in pharmaceutical manufacturing, the demand for high-quality primary packaging solutions has surged, driven by the rise in vaccine production, biologics, and injectable therapies. The CCI’s approval paves the way for enhanced investments, technological advancements, and global expertise infusion in India's pharmaceutical packaging segment. The partnership between TPG and SPPL is expected to strengthen supply chain efficiencies, improve manufacturing capabilities, and support innovation in sterile and injectable packaging solutions. Market and Industry Outlook India’s pharmaceutical packaging market is witnessing robust growth, propelled by increasing regulatory requirements, demand for biologics, and the rise of single-dose drug delivery systems. The expansion of vaccine production and the growth of biosimilars and novel therapies have amplified the need for advanced packaging solutions. With global investors such as TPG entering the segment, the industry is poised for enhanced technological collaborations, automation in manufacturing, and sustainable packaging innovations. The acquisition of a stake in Schott Poonawalla Private Limited is expected to strengthen India’s position as a global hub for pharmaceutical packaging, ensuring compliance with stringent international standards while catering to the evolving needs of the pharmaceutical industry.

Real Estate

05 Sep 2025

Vitizen Hotels Signs Deal at Manyata Tech Park

Vikram Kamats Hospitality, as part of its ongoing expansion in key metropolitan markets, announced that its material subsidiary, Vitizen Hotels, has signed a long-term lease agreement for a 45-key hotel property at Manyata Tech Park, Bengaluru.Strategically located in the city’s prominent IT hub, the property is well-positioned to serve corporate travelers, business professionals, and long-stay guests. The addition aligns with the company’s asset-light growth model, leveraging long-term leases to expand its footprint in high-demand urban markets.The hotel is expected to strengthen the comp..

Infrastructure Transport

05 Sep 2025

CONCOR Signs MoU with BPIPL to Operate Container Terminal at Bhavnagar Port

Container Corporation of India (CONCOR) has signed a Memorandum of Understanding (MoU) with Bhavnagar Port Infrastructure (BPIPL) on September 4, 2025, in New Delhi to operate and maintain the upcoming container terminal at the northside of Bhavnagar Port, Gujarat.BPIPL had earlier entered into an agreement with the Gujarat Maritime Board (GMB) in September 2024 for the port’s development. Under this arrangement, 235 hectares of land has been leased to BPIPL for 30 years, with provision for expansion by an additional 250 hectares.The new terminal is expected to significantly enhance logistic..

Infrastructure Transport

05 Sep 2025

Concord Launches India’s First Indigenous Zero-Emission Rail Propulsion

Concord Control Systems (CCSL), a leader in embedded electronics and critical rail technologies, has announced the development of India’s first fully indigenous zero-emission propulsion system, marking a significant step toward the country’s railway electrification and net-zero goals for 2030.Powered by Lithium Iron Phosphate (LFP) batteries and featuring a DC chopper-based drive, the propulsion system eliminates idling losses common in diesel engines, offering higher efficiency, lower costs, and zero emissions.What sets this innovation apart is its completely indigenous design. Except for..